Related Experiment Video
Updated: Dec 20, 2025
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease
Yeon Wook Kim1, Chang-Hoon Lee2, Hun-Gyu Hwang3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Most chronic obstructive pulmonary disease (COPD) patients experience a decline in carbon monoxide transfer coefficient (Kco) over time. This Kco decline is linked to worse lung function and more frequent exacerbations in COPD.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Reduced carbon monoxide transfer coefficient (Kco) is a key indicator in chronic obstructive pulmonary disease (COPD).
- Longitudinal changes in Kco and their clinical implications in COPD are not fully understood.
Purpose of the Study:
- To evaluate the longitudinal changes in Kco in patients with COPD.
- To investigate the relationship between Kco decline and other clinical outcomes in COPD.
Main Methods:
- Analysis of data from the Korean Obstructive Lung Disease cohort, with up to ten years of follow-up.
- Utilized random coefficient models to assess annual Kco changes.
- Categorized patients into tertiles based on Kco decline rate for comparative analysis.
Main Results:
- A Kco decline was observed in 92.9% of 211 COPD participants.
- Rapid Kco decline correlated with lower baseline FEV1/FVC% and higher emphysema index.
- Slower Kco decline was associated with a reduced FEV1 decline rate and fewer exacerbations.
Conclusions:
- Kco decline is a common longitudinal change in COPD, more pronounced in severe airflow limitation and emphysema.
- Kco decline is a significant predictor of accelerated FEV1 decline and increased exacerbation frequency.
- Kco should be considered a valuable outcome measure in future COPD research.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: